Sector revisions DexCom, Inc.

Stocks

Market Closed - Nasdaq 16:00:00 2026-10-02 EDT			5-day change	1st Jan Change
85.36 ^USD	-1.01%		-1.45%	+28.61%

10-01	RBC Raises Price Target on DexCom to $105 From $90, Keeps Outperform Rating	MT
09-28	Dexcom Publishes New Report During Easd 2026 on Type 2 Diabetes Revealing Critical Opportunity for Global Diabetes Care	CI

Sector:

Location:

X axis:

Main competitors

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	1m. Revenue rev.	4m. EPS revision	4m. Revenue rev.	1y. EPS revision	1y. Revenue rev.	Visibility	Nbr of analysts
	DEXCOM, INC.							25
	ABBOTT LABORATORIES							25
	MEDTRONIC PLC							24
	STRYKER CORPORATION							25
	ESSILORLUXOTTICA							23
	CENCORA, INC.							12
	HOYA CORPORATION							15
	BECTON, DICKINSON AND COMPANY							12
	IDEXX LABORATORIES, INC.							12
	MEDLINE INC.							26
	ALCON INC.							17
	WEST PHARMACEUTICAL SERVICES, INC.							16
	GUARDANT HEALTH, INC.							25
	SARTORIUS STEDIM BIOTECH							14
	TERUMO CORPORATION							13
	STERIS PLC							8
	SONOVA HOLDING AG							19
	STRAUMANN HOLDING AG							19
	ZIMMER BIOMET HOLDINGS, INC.							21
	FISHER & PAYKEL HEALTHCARE CORPORATION LIMITED							11
	Average							18
	Weighted average by Cap.							20